Pharmacist Value-Added Service - Dr. Z - APP Exam 1

Match the following steps in pharmacist patient care process (PPCP) with their proper descriptions

• Assess

• Determining the patient's progress toward therapeutic goals, evaluating wether they have atteined the goals

• Plan

• Working with patient's physicians, nurses, and other health care providers as well as caregivers in collabaration

• Implement

• Considering all information in order to make a decision regarding the appropriateness, effectiveness, and safety of a patients therapy

• Plan

• The patients med history, laboratory data, assessment findings, social history, and lifestyle habits

• Collect

• An individualized plan that address the patients medications related problems and sets goals for therapy

Select all of the following value-added services that pharmacist can implement

• Medication therapy management

• Monitoring/screening and wellness/Health-promotion services

• Disease-state management

• Case management

• Life advice

Match the following medication therapy managements types with their descriptions

• Continuous medication management (CMM)

• Occurs during the dispensing process when a mediation therapy problem is identified

• Comprehensive

• Incorporates a comprehensive review of the medication profile into medication dispensing process for all patients as rx are prescribed

• Focused MTM

• Identifies all problems with a patient's medical therapy. The workup and recommendations are shared with the patient and the physician

• Appointment based model

• Pharmacist proactively reviews the patient profile

Categorize these different parts of the pharmacist patient care process (PPCP) into which categories they fall under

Groups:

(a) Collect

,

(b) Asess

,

(c) Plan and implement

,

(d) Follow-up

• working in collaboration with patient, caregivers, and health care team

• Medication history

• Social history

• Physical assessment findings

• Monitor patients progress

• Determining if they obtained goals

• Setting goals for therapy

• Coming up with a individualized plan to help the patient

• Laboratory data

• Appropriatness

• Adherence
  

• Evaluate patients progress towards therapeutic goals

• Effectiveness

• safety

Collaboration, communication, and documentation should only occur in the Plan, implementation and follow-up parts of the PCPP

• True

• False

All of the following are true for medication management protocols (the collaborative practice agreements) EXCEPT

• Physicians and pharmacist sign the CPA and a copy should be kept at the pharmacy or physicians practice

• CPAs should be cost-based and supported by national guidelines and the primary literature

• CPAs should be developed to help guide the pharmacists therapeutic decisions

• CPAs should be evidence-based and supported by national guidelines and primary literature

• CPAs hold no real particle place in medication management

CLIA waived test are considered by both the CDC and FDA as difficult test to administer with a higher risk of error.

• True

• False

Pharmacist providing CLIA waived test agree to follow good laboratory practices

• True

• False

Pharmacies implementing monitoring or screening services that utilize devices that measure patients specimens need to apply for which of the following

• OSHA waiver

• CLIA wavier

• HIPPA Waiver

• CDA waiver